The State of Hawaii has reached a settlement agreement with pharmaceutical companies accused of defrauding the state's Medicaid system by overcharging for medications. The State will receive more than $82 million from a number of different drug companies involved in the litigation, which accused the companies of marketing and selling prescription drugs using fraudulent and inflated "average wholesale price" figures.
Beasley Allen has filed a class action lawsuit in Circuit Court of Montgomery, Alabama, on behalf of a local woman, individually and as a class representative against Defendants Colonial Management Group, L.P.; Colonial GP, L.P.; and Montgomery Liquidating Professional Corporation d/b/a Montgomery Metro Treatment Center; and Gilberto Sanchez, M.D.
W. Daniel "Dee" Miles, III has been selected for inclusion in the 2010 edition of The Heritage Registry of Who's Who. Miles is a shareholder with Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., law firm in Montgomery, and head of the firm's Consumer Fraud Section. Miles was selected in recognition of his accomplishments and achievements attained in the field of Legal Services.
Beasley Allen founding shareholder Jere L. Beasley speaks out on recent Alabama Supreme Court decision in state Medicaid Fraud lawsuits; asks Court to grant oral argument.
The Alabama Supreme Court refused the State of Alabama's request for oral argument in three of the most important cases to be heard by this Court in recent years.
In a shocking development, the Alabama Supreme Court reversed three of the State of Alabama's Medicaid fraud lawsuits that were on appeal. The court refused the state's multiple requests for oral argument in the cases, considered to be among the most important cases to be heard by this Court in recent years. To say the least, that was more than just unusual. The case against AstraZeneca, one of the defendants, had been on appeal for 13 months.
A Montgomery County jury found Sandoz Pharmaceuticals, Inc., guilty of Medicaid fraud on Feb. 24, and ordered the manufacturer to pay the State of Alabama $28.4 million in compensatory damages and $50 million in punitive damages. Documents presented in the state's case against Sandoz indicate a long history of inflating prices on its generic drugs to increase its market share, defrauding the state's Medicaid system. During the trial, several critical documents were shown to jurors, which prove Sandoz intentionally defrauded the state.
MONTGOMERY, ALA. - (February 6, 2009) Beasley Allen has re-filed the lawsuit on behalf of the City of Birmingham against various sub-prime lenders including CitiGroup, Inc., Citi Mortgage, Inc., Citi Financial, Inc., Argent Mortgage Company, LLC, and Countrywide. The suit contends that the companies have violated the Fair Housing Act (FHA) by participating in predatory lending practices. The lawsuit also alleges the lenders violated other state laws and have profited by their wrongdoing.
MONTGOMERY, ALA. (February 5, 2009) - Beasley Allen is preparing to represent the State of Alabama in its third trial in the Average Wholesale Price (AWP) litigation, in which pharmaceutical companies are accused of defrauding the state Medicaid system. The trial, which will begin Monday, Feb. 9, in Montgomery County Circuit Court, alleges that Sandoz Pharmaceuticals, Inc., of provided inaccurate prices for Medicaid reimbursement, costing taxpayers millions of dollars.



